A000223

Organization name

WH Pharmawerk Weinböhla GmbH

SRN

DE-MF-000006741

Manufacturer status

Active

5 warnings recorded — scroll inside the panel to see all entries.

• CW999

  OMNi-LOGiC® HUMIN is not suitable for the treatment of constipation.
• CW999

  Potential interaction with other products (e.g. medicines, food) OMNi-LOGiC® HUMIN should not be taken within a period of 2 hours of other medication having been taken (especially such with a low therapeutic effect, e.g. hormones, chemotherapeutic substances) and food supplements (vitamins, minerals), as their effects are impaired by the binding characteristic of the humin acids, thereby resulting in interactions occurring. OMNi-LOGiC® HUMIN should only be taking after consulting the treating physician when taking retard preparations.
• CW999

  Contraindication: Hypersensitivity toward humin acids or the capsule material.
• CW999

  The content of the capsules has a strong colouring effect.
• CW999

  Keep OMNi-LOGiC® HUMIN out of the reach of children!

Primary placement in Germany; available across 2 countries total.

Trade name

not provided

UDI-DI code

04260631560304

Basic UDI-DI

B-04260631560304

Reference / catalog number

A000223

Issuing entity

GS1

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

OMNi-LOGiC® HUMIN is a medical product in capsule form for oral use: • with unspecific diarrhoea, • with gastrointestinal symptoms, • for the binding of harmful substances and toxins.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 120 MU999

• G0499ORALLY ADMINISTERED GASTROINTESTINAL DEVICES - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification